Scienture Holdings, Inc. - Common Stock (SCNX)
0.3800
+0.00 (0.00%)
NASDAQ· Last Trade: Jun 5th, 7:54 AM EDT
COMMACK, NY / ACCESS Newswire / June 4, 2026 / SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel specialty products that address unmet market needs, today announced that members of its executive management team will participate in The Small Cap Showcase & WTR Insights, taking place on June 9, 2026, in New York City.
Via ACCESS Newswire · June 4, 2026
RALEIGH, NC / ACCESS Newswire / December 8, 2025 / iAccess Alpha's Virtual Best Ideas Winter Investment Conference will take place on December 9-10, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities.
Via ACCESS Newswire · December 8, 2025
RALEIGH, NC / ACCESS Newswire / December 1, 2025 / iAccess Alpha's Virtual Best Ideas Winter Investment Conference will take place on December 9-10, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities.
Via ACCESS Newswire · December 1, 2025
Specificity Inc. (OTCQB: SPTY), the fast-scaling ad tech disruptor redefining digital marketing precision, today announced that its Form S-1 Registration Statement , initially filed with the U.S. Securities and Exchange Commission on October 14, 2025 , has been declared effective . This milestone fully restores Specificity’s SEC reporting compliance and activates the company’s STRATA Agreement with an institutional investor, providing access to new capital for expansion.
Via AB Newswire · November 4, 2025
Specificity, Inc. (OTCQB: SPTY), a fast-scaling ad tech disruptor redefining digital marketing precision, has seen its stock skyrocket 933% this week, rallying from an intraday low of $0.15 on October 16 to an intraday high of $1.40 on October 22 , as Wall Street responds enthusiastically to the company’s new executive appointments and aggressive growth trajectory.
Via AB Newswire · October 23, 2025